These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33213537)

  • 1. Risk factors for the development of infections associated with carbapenemase-producing
    Jimenez A; Fennie K; Munoz-Price LS; Ibrahimou B; Abbo LM; Martinez O; Sposato K; Doi Y; Trepka MJ
    Infect Control Hosp Epidemiol; 2021 Jun; 42(6):763-766. PubMed ID: 33213537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
    Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Useful independent factors for distinguish infection and colonization in patients with urinary carbapenemase-producing Enterobacteriaceae isolation.
    López-González L; Candel FJ; Viñuela-Prieto JM; González-Del Castillo J; García AB; Pena I; Rodríguez-Avial I
    Rev Esp Quimioter; 2017 Dec; 30(6):450-457. PubMed ID: 29115369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Intra-Abdominal Infections Caused by Carbapenemase-Producing
    Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
    Surg Infect (Larchmt); 2021 Oct; 22(8):864-870. PubMed ID: 33857380
    [No Abstract]   [Full Text] [Related]  

  • 6. Description of carbapenemase-producing Enterobacteriaceae isolates in a Spanish tertiary hospital. Epidemiological analysis and clinical impact.
    López-González L; Viñuela-Prieto JM; Rodriguez-Avial I; Manzano R; Candel FJ
    Rev Esp Quimioter; 2019 Jun; 32(3):254-262. PubMed ID: 30968674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea.
    Park JW; Lee H; Park SY; Kim TH
    Antimicrob Resist Infect Control; 2019; 8():48. PubMed ID: 30873279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetic acid as a decontamination method for ICU sink drains colonized by carbapenemase-producing Enterobacteriaceae and its effect on CPE infections.
    Smolders D; Hendriks B; Rogiers P; Mul M; Gordts B
    J Hosp Infect; 2019 May; 102(1):82-88. PubMed ID: 30579969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.
    Hernández-García M; Pérez-Viso B; Carmen Turrientes M; Díaz-Agero C; López-Fresneña N; Bonten M; Malhotra-Kumar S; Ruiz-Garbajosa P; Cantón R
    J Antimicrob Chemother; 2018 Nov; 73(11):3039-3043. PubMed ID: 30053018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and outcomes of patients colonized with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant
    Kassem A; Raed A; Michael T; Sagi O; Shimoni O; Borer A; Saidel-Odes L
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1154-1161. PubMed ID: 32624034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
    Kim SH; Kim GR; Jeong J; Kim S; Shin JH
    Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-Abdominal Infections by Carbapenemase-Producing
    Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
    Surg Infect (Larchmt); 2021 Apr; 22(3):266-273. PubMed ID: 32598237
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.
    Eda R; Nakamura M; Takayama Y; Maehana S; Nakano R; Yano H; Kitasato H
    J Infect Chemother; 2020 Jul; 26(7):667-671. PubMed ID: 32222331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
    Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
    Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.
    Lim YJ; Park HY; Lee JY; Kwak SH; Kim MN; Sung H; Kim SH; Choi SH
    Clin Microbiol Infect; 2018 Oct; 24(10):1104.e5-1104.e8. PubMed ID: 29870856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
    Tängdén T; Giske CG
    J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.
    Boonyasiri A; Jauneikaite E; Brinkac LM; Greco C; Lerdlamyong K; Tangkoskul T; Nguyen K; Thamlikitkul V; Fouts DE
    BMC Infect Dis; 2021 Feb; 21(1):142. PubMed ID: 33541274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries.
    Villegas MV; Pallares CJ; Escandón-Vargas K; Hernández-Gómez C; Correa A; Álvarez C; Rosso F; Matta L; Luna C; Zurita J; Mejía-Villatoro C; Rodríguez-Noriega E; Seas C; Cortesía M; Guzmán-Suárez A; Guzmán-Blanco M
    PLoS One; 2016; 11(4):e0154092. PubMed ID: 27104910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Carbapenemase producing Enterobacteriaceae in the Netherlands: unnoticed spread to several regions].
    Leenstra T; Bosch T; Vlek AL; Bonten MJM; van der Lubben IM; de Greeff SC
    Ned Tijdschr Geneeskd; 2017; 161():D1585. PubMed ID: 29076442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.